Similar articles

• 'Safapryn' and benorylate--a comparative trial of two new preparations of aspirin and paracetamol in the treatment of rheumatoid arthritis and osteoarthritis.

  Maneksha S. Maneksha S. Curr Med Res Opin. 1973;1(9):563-8. doi: 10.1185/03007997309111722. Curr Med Res Opin. 1973. PMID: 4591823 Clinical Trial. No abstract available.
• [Clinical study on a new acetylsalicylic acid/paracetamol preparation with gastric acid resistant coating (Safapryn), and on two various phenylbutazone dosages in patients with primary chronic polyarthritis as based on a new evaluation method].

  Brooks PM, Walker JJ, Lee P, Bell AM, Buchanan WW, Fowler PD, Anderson JA. Brooks PM, et al. Z Rheumatol. 1975 Sep-Oct;34(9-10):350-65. Z Rheumatol. 1975. PMID: 1106038 Clinical Trial. German.
• [Enteric aspirin tablets and the salicylate concentration in the plasma in the morning].

  Laine V, Strandman D, Tikkanen R. Laine V, et al. Lakartidningen. 1968 Sep 25;65(39):3832-7 passim. Lakartidningen. 1968. PMID: 5741894 Swedish. No abstract available.
• Advances in the treatment of rheumatic diseases.

  Jayson MI. Jayson MI. Practitioner. 1973 Oct;211(264):483-90. Practitioner. 1973. PMID: 4583810 Review. No abstract available.
• New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.

  Hochberg MC. Hochberg MC. Semin Arthritis Rheum. 2002 Dec;32(3 Suppl 1):4-14. doi: 10.1053/sarh.2002.37215. Semin Arthritis Rheum. 2002. PMID: 12528069 Review.